Challenges of Maintaining Good Clinical Laboratory Practices in Low-Resource Settings:  A Health Program Evaluation Framework Case Study From East Africa.

OBJECTIVES Using a clinical research laboratory as a case study, we sought to characterize barriers to maintaining Good Clinical Laboratory Practice (GCLP) services in a developing world setting. METHODS Using a US Centers for Disease Control and Prevention framework for program evaluation in public health, we performed an evaluation of the Kilimanjaro Christian Medical Centre-Duke University Health Collaboration clinical research laboratory sections of the Kilimanjaro Clinical Research Institute in Moshi, Tanzania. Laboratory records from November 2012 through October 2014 were reviewed for this analysis. RESULTS During the 2-year period of study, seven instrument malfunctions suspended testing required for open clinical trials. A median (range) of 9 (1-55) days elapsed between instrument malfunction and biomedical engineer service. Sixteen (76.1%) of 21 suppliers of reagents, controls, and consumables were based outside Tanzania. Test throughput among laboratory sections used a median (range) of 0.6% (0.2%-2.7%) of instrument capacity. Five (55.6%) of nine laboratory technologists left their posts over 2 years. CONCLUSIONS These findings demonstrate that GCLP laboratory service provision in this setting is hampered by delays in biomedical engineer support, delays and extra costs in commodity procurement, low testing throughput, and high personnel turnover.

[1]  D. Katzenstein,et al.  Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings , 2012, AIDS.

[2]  Abdesslam Boutayeb,et al.  International Journal for Equity in Health the Burden of Non Communicable Diseases in Developing Countries , 2005 .

[3]  J. Montaner,et al.  Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries. , 2013, The Journal of infectious diseases.

[4]  Timothy Amukele,et al.  External quality assurance performance of clinical research laboratories in sub-saharan Africa. , 2012, American journal of clinical pathology.

[5]  D. Birx,et al.  Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery. , 2009, American journal of clinical pathology.

[6]  D. Menzies,et al.  Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs , 2015, BMC Public Health.

[7]  J. Gerberding,et al.  Morbidity and Mortality Weekly Report Prevention of Hepatitis a through Active or Passive Immunization Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Coordinating Center for Health Information and Service Recommendations and Repo , 2022 .

[8]  Cathy A Petti,et al.  Laboratory medicine in Africa: a barrier to effective health care. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Bobby Milstein,et al.  Framework for program evaluation in public health , 1999 .

[10]  J. Crump,et al.  Evaluation of In-Hospital Management for Febrile Illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the Treatment of Malaria , 2014, PloS one.

[11]  Carole L. Wallis,et al.  Laboratory Challenges Conducting International Clinical Research in Resource-Limited Settings , 2014, Journal of acquired immune deficiency syndromes.

[12]  T. Kenyon,et al.  Laboratory equipment maintenance: A critical bottleneck for strengthening health systems in sub-Saharan Africa? , 2012, Journal of public health policy.

[13]  P. J. Russell A is for Africa , 2017 .

[14]  L. Reller,et al.  Clinical microbiology in developing countries. , 2001, Emerging infectious diseases.

[15]  R. Atun,et al.  Adoption of Rapid Diagnostic Tests for the Diagnosis of Malaria, a Preliminary Analysis of the Global Fund Program Data, 2005 to 2010 , 2012, PloS one.

[16]  J. Salomon,et al.  Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation , 2012, PLoS medicine.

[17]  E. Bendavid,et al.  HIV development assistance and adult mortality in Africa. , 2012, JAMA.

[18]  C. Whitty,et al.  Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study , 2008, Malaria Journal.

[19]  A. Abimiku Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. , 2009, American journal of clinical pathology.

[20]  Clement Zeh,et al.  The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region. , 2010, American journal of clinical pathology.

[21]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[22]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  M. Hughes,et al.  Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. , 2012, The New England journal of medicine.

[24]  Audrey Albertini,et al.  Reductions in Artemisinin-Based Combination Therapy Consumption after the Nationwide Scale up of Routine Malaria Rapid Diagnostic Testing in Zambia , 2012, The American journal of tropical medicine and hygiene.

[25]  Jeffrey Wasserman,et al.  Strengthening laboratory systems in resource-limited settings. , 2010, American journal of clinical pathology.

[26]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[27]  C. Whitty,et al.  Malaria overdiagnosis: is patient pressure the problem? , 2008, Health policy and planning.

[28]  O. Doumbo,et al.  Promoting good clinical laboratory practices and laboratory accreditation to support clinical trials in sub-Saharan Africa. , 2012, The American journal of tropical medicine and hygiene.